Jennifer J. Hu
University of Miami
148 Papers
991 Citations
Jennifer J. Hu is an academic researcher from University of Miami. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 43, co-authored 135 publications. Previous affiliations of Jennifer J. Hu include Rutgers University & Georgetown University Medical Center.
Chat about Author
Papers
Risk assessment, prevention and early detection of breast cancer related lymphedema: Objective measurements and patient reported outcomes.
Anshumi Desai,Orli Friedman Eldar,Gili G. Halfteck,Mecker G Moller,Dido Franceschi,Susan B. Kesmodel,Neha Mukesh Goel,Jessica Crystal,Laura Y. Huang,Diana M. Molinares,Jennifer J. Hu,Tulay Koru-Sengul,Wei Zhao,A. R. Narvaez-Rojas,Eli Avisar +14 more
TL;DR: These preliminary results validate the use of PROs alongside objective measurements to assess BCRL, and LYMPHA and S-LYMPHA significantly reduce lymphedema rates.
1
Important Roles of ERCC1 in DNA Repair and Targeted Therapy
Jennifer J. Hu,Joseph de la Garza,Sathish Srinivasan,Ann Alyssa Kurian,Feng Gong +4 more
- 01 Jan 2013
TL;DR: While most of the DNA repair proteins function only in a specific repair pathway, ERCC1–XPF is involved in multiple DNA repair pathways and telomere maintenance, making this heterodimer not only an attractive therapeutic target, but also a biomarker to predict treatment outcome.
1
•Journal Article
DNA repair pathways: Genetic determinants of disparities in prostate and colon cancer.
TL;DR: Two studies conducted to pilot test whether germline nonsynonymous coding single nucleotide polymorphisms (nsSNP) of DNA-repair genes may contribute to racial/ethnic differences in prostate or colon cancer risk and progression and establish and validate gene-environment human cancer risk models and translate this information into health behavior promotion in genetically susceptible populations.
1
Abstract 2824: Metabolomics in radiotherapy-induced early adverse skin reactions in breast cancer patients
Cristiane Takita,Jean L. Wright,Eunkyung Lee,Joshua Kleinman,Isildinha M. Reis,Jennifer J. Hu +5 more
TL;DR: McMahon et al. as discussed by the authors used global metabolomics profiles of breast cancer populations to identify metabolic pathways and biomarkers that are significantly associated with postoperative adjuvant radiotherapy (RT)induced early adverse skin reactions (EASRs) to identify potential targets for precision interventions.
Abstract 3052: Patient- and clinician-reported outcomes of radiotherapy-related acute skin toxicities in a tri-racial/ethnic breast cancer population
TL;DR: In this paper , Acosta et al. evaluated the impact of adjuvant radiotherapy-related acute skin toxicities on patients' quality of life (QOL) in a tri-racial/ethnic breast cancer population with 85% minorities.